Process View
The directed movement of a protein from the nucleus into the cytoplasm.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "protein export from nucleus"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.845 | ||
| STK11 | serine/threonine kinase 11 | 0.728 | ||
| YAP1 | Yes-associated protein 1 | 0.443 | ||
| DAXX | death-domain associated protein | 0.442 | ||
| WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.435 | Human | |
| AXIN1 | axin 1 | 0.389 | ||
| KPNB1 | karyopherin (importin) beta 1 | 0.341 | ||
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.325 | Human | |
| NXF1 | nuclear RNA export factor 1 | 0.299 | ||
| IFI44L | interferon-induced protein 44-like | 0.283 | ||
| SMAD7 | SMAD family member 7 | 0.265 | ||
| PAX3 | paired box 3 | 0.244 | ||
| MMS22L | MMS22-like, DNA repair protein | 0.218 | ||
| XPO1 | exportin 1 (CRM1 homolog, yeast) | 0.213 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.184 | ||
| AR | androgen receptor | 0.132 | ||
| NUP62 | nucleoporin 62kDa | 0.124 | ||
| RCC1 | regulator of chromosome condensation 1 | 0.112 | ||
| UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.102 | ||
| RAN | RAN, member RAS oncogene family | 0.069 | ||
| WASL | Wiskott-Aldrich syndrome-like | 0.068 | ||
| TNPO1 | transportin 1 | 0.067 | ||
| PPM1A | protein phosphatase, Mg2+/Mn2+ dependent, 1A | 0.065 | ||
| YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide | 0.063 | ||
| RANBP9 | RAN binding protein 9 | 0.063 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.060 | ||
| NCL | nucleolin | 0.057 | ||
| FBXW11 | F-box and WD repeat domain containing 11 | 0.055 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.054 | ||
| SMAD4 | SMAD family member 4 | 0.052 | ||
| SOD1 | superoxide dismutase 1, soluble | 0.052 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.051 | ||
| PKD2 | polycystic kidney disease 2 (autosomal dominant) | 0.051 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.050 | ||
| IRF9 | interferon regulatory factor 9 | 0.050 | ||
| SKP1 | S-phase kinase-associated protein 1 | 0.048 | ||
| FSTL1 | follistatin-like 1 | 0.047 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.047 | ||
| GHR | growth hormone receptor | 0.046 | ||
| PRDX1 | peroxiredoxin 1 | 0.045 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.044 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.043 | ||
| CXXC5 | CXXC finger protein 5 | 0.040 | ||
| PSIP1 | PC4 and SFRS1 interacting protein 1 | 0.039 | ||
| ELK1 | ELK1, member of ETS oncogene family | 0.038 | ||
| CASP8AP2 | caspase 8 associated protein 2 | 0.038 | ||
| POU3F2 | POU class 3 homeobox 2 | 0.037 | ||
| NUP98 | nucleoporin 98kDa | 0.036 | ||
| HMGB2 | high mobility group box 2 | 0.036 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.036 | ||
| ANKRD13A | ankyrin repeat domain 13A | 0.036 | ||
| AXL | AXL receptor tyrosine kinase | 0.036 | ||
| BTRC | beta-transducin repeat containing | 0.035 | ||
| WWP1 | WW domain containing E3 ubiquitin protein ligase 1 | 0.035 | Human | |
| AKIP1 | A kinase (PRKA) interacting protein 1 | 0.035 | ||
| BST2 | bone marrow stromal cell antigen 2 | 0.034 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.032 | ||
| JUP | junction plakoglobin | 0.032 | ||
| RSAD2 | radical S-adenosyl methionine domain containing 2 | 0.031 | ||
| CTTN | cortactin | 0.031 | ||
| NUP54 | nucleoporin 54kDa | 0.031 | ||
| MX1 | myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) | 0.030 | ||
| NUCKS1 | nuclear casein kinase and cyclin-dependent kinase substrate 1 | 0.030 | ||
| ISG15 | ISG15 ubiquitin-like modifier | 0.030 | ||
| TCF4 | transcription factor 4 | 0.029 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.029 | Human | |
| MAP2K1 | mitogen-activated protein kinase kinase 1 | 0.029 | ||
| DEDD | death effector domain containing | 0.028 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.028 | ||
| EIF2AK2 | eukaryotic translation initiation factor 2-alpha kinase 2 | 0.027 | ||
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.027 | ||
| MAPT | microtubule-associated protein tau | 0.027 | ||
| STAT1 | signal transducer and activator of transcription 1, 91kDa | 0.027 | ||
| PML | promyelocytic leukemia | 0.027 | ||
| EIF4E | eukaryotic translation initiation factor 4E | 0.027 | ||
| IFI44 | interferon-induced protein 44 | 0.026 | ||
| RYR2 | ryanodine receptor 2 (cardiac) | 0.026 | ||
| PIN1 | peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 0.026 | ||
| DDX58 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 | 0.026 | ||
| IPO5 | importin 5 | 0.025 | ||
| TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 0.025 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.025 | ||
| NUP50 | nucleoporin 50kDa | 0.024 | ||
| TRIM21 | tripartite motif containing 21 | 0.024 | ||
| HNRNPD | heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa) | 0.024 | ||
| CDK5R1 | cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 0.024 | ||
| SCNN1B | sodium channel, nonvoltage-gated 1, beta | 0.023 | ||
| SP100 | SP100 nuclear antigen | 0.023 | ||
| ADAR | adenosine deaminase, RNA-specific | 0.023 | ||
| SET | SET nuclear oncogene | 0.023 | ||
| RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.023 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.023 | ||
| IFIT1 | interferon-induced protein with tetratricopeptide repeats 1 | 0.022 | ||
| RAPGEF2 | Rap guanine nucleotide exchange factor (GEF) 2 | 0.022 | ||
| XPO5 | exportin 5 | 0.022 | ||
| NMI | N-myc (and STAT) interactor | 0.021 | ||
| MAPK1 | mitogen-activated protein kinase 1 | 0.021 | Yeast | |
| IFIT5 | interferon-induced protein with tetratricopeptide repeats 5 | 0.021 | ||
| BRF2 | BRF2, subunit of RNA polymerase III transcription initiation factor, BRF1-like | 0.021 | ||
| RANBP1 | RAN binding protein 1 | 0.021 | ||
| CABLES1 | Cdk5 and Abl enzyme substrate 1 | 0.021 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.021 | ||
| PSEN1 | presenilin 1 | 0.021 | ||
| HSPD1 | heat shock 60kDa protein 1 (chaperonin) | 0.020 | ||
| UBE2L6 | ubiquitin-conjugating enzyme E2L 6 | 0.020 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.020 | ||
| SPRR2A | small proline-rich protein 2A | 0.020 | ||
| MAPK9 | mitogen-activated protein kinase 9 | 0.019 | ||
| IPO13 | importin 13 | 0.019 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.019 | ||
| HMGN2 | high mobility group nucleosomal binding domain 2 | 0.019 | ||
| WNK1 | WNK lysine deficient protein kinase 1 | 0.018 | ||
| PLSCR1 | phospholipid scramblase 1 | 0.018 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.018 | ||
| EMD | emerin | 0.018 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.017 | ||
| EGR1 | early growth response 1 | 0.017 | ||
| DUSP3 | dual specificity phosphatase 3 | 0.017 | Yeast | |
| PPIF | peptidylprolyl isomerase F | 0.017 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.017 | ||
| PARP12 | poly (ADP-ribose) polymerase family, member 12 | 0.017 | ||
| MAPK3 | mitogen-activated protein kinase 3 | 0.017 | Yeast | |
| SMAD1 | SMAD family member 1 | 0.016 | ||
| FBXL15 | F-box and leucine-rich repeat protein 15 | 0.016 | ||
| ADAM15 | ADAM metallopeptidase domain 15 | 0.016 | ||
| SPG20 | spastic paraplegia 20 (Troyer syndrome) | 0.016 | ||
| HNRNPL | heterogeneous nuclear ribonucleoprotein L | 0.016 | ||
| KDM2A | lysine (K)-specific demethylase 2A | 0.016 | ||
| PRKAR1B | protein kinase, cAMP-dependent, regulatory, type I, beta | 0.016 | ||
| OAS1 | 2',5'-oligoadenylate synthetase 1, 40/46kDa | 0.015 | ||
| IFI16 | interferon, gamma-inducible protein 16 | 0.015 | ||
| KAT5 | K(lysine) acetyltransferase 5 | 0.015 | ||
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.015 | ||
| HYOU1 | hypoxia up-regulated 1 | 0.015 | ||
| GOLGA2 | golgin A2 | 0.015 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.015 | ||
| KPNA1 | karyopherin alpha 1 (importin alpha 5) | 0.014 | ||
| PIAS4 | protein inhibitor of activated STAT, 4 | 0.014 | ||
| ZFPM1 | zinc finger protein, multitype 1 | 0.014 | ||
| CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | 0.014 | ||
| CCT4 | chaperonin containing TCP1, subunit 4 (delta) | 0.014 | ||
| NEK1 | NIMA (never in mitosis gene a)-related kinase 1 | 0.014 | ||
| PTMA | prothymosin, alpha | 0.014 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.014 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.014 | ||
| PPP5C | protein phosphatase 5, catalytic subunit | 0.014 | ||
| SAMD9 | sterile alpha motif domain containing 9 | 0.014 | ||
| HDAC4 | histone deacetylase 4 | 0.014 | ||
| FIBP | fibroblast growth factor (acidic) intracellular binding protein | 0.014 | ||
| SENP1 | SUMO1/sentrin specific peptidase 1 | 0.014 | ||
| HNRNPUL1 | heterogeneous nuclear ribonucleoprotein U-like 1 | 0.014 | ||
| HMGB1 | high mobility group box 1 | 0.013 | ||
| TPR | translocated promoter region (to activated MET oncogene) | 0.013 | ||
| ITCH | itchy E3 ubiquitin protein ligase homolog (mouse) | 0.013 | Human | |
| MARK2 | MAP/microtubule affinity-regulating kinase 2 | 0.013 | ||
| ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 0.013 | ||
| MARCKSL1 | MARCKS-like 1 | 0.013 | ||
| IFI35 | interferon-induced protein 35 | 0.013 | ||
| APC | adenomatous polyposis coli | 0.013 | Worm | |
| CHORDC1 | cysteine and histidine-rich domain (CHORD) containing 1 | 0.013 | ||
| LAP3 | leucine aminopeptidase 3 | 0.013 | ||
| FTSJD2 | FtsJ methyltransferase domain containing 2 | 0.013 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.013 | ||
| PEA15 | phosphoprotein enriched in astrocytes 15 | 0.013 | ||
| ZEB2 | zinc finger E-box binding homeobox 2 | 0.013 | ||
| TNIK | TRAF2 and NCK interacting kinase | 0.013 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.012 | ||
| SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.012 | ||
| ERO1L | ERO1-like (S. cerevisiae) | 0.012 | ||
| NUP214 | nucleoporin 214kDa | 0.012 | ||
| ATRX | alpha thalassemia/mental retardation syndrome X-linked | 0.012 | ||
| ERBB2IP | erbb2 interacting protein | 0.012 | ||
| STRN3 | striatin, calmodulin binding protein 3 | 0.012 | ||
| MBD1 | methyl-CpG binding domain protein 1 | 0.012 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.012 | ||
| PHF11 | PHD finger protein 11 | 0.012 | ||
| B2M | beta-2-microglobulin | 0.012 | ||
| AP2B1 | adaptor-related protein complex 2, beta 1 subunit | 0.012 | ||
| PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.012 | ||
| CBX1 | chromobox homolog 1 | 0.012 | ||
| PPP2CA | protein phosphatase 2, catalytic subunit, alpha isozyme | 0.012 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.012 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.012 | Fly | |
| LEF1 | lymphoid enhancer-binding factor 1 | 0.011 | Human | |
| PXN | paxillin | 0.011 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.011 | ||
| ANP32A | acidic (leucine-rich) nuclear phosphoprotein 32 family, member A | 0.011 | Human | |
| VRK2 | vaccinia related kinase 2 | 0.011 | ||
| PSTPIP1 | proline-serine-threonine phosphatase interacting protein 1 | 0.011 | ||
| DEAF1 | deformed epidermal autoregulatory factor 1 (Drosophila) | 0.011 | ||
| SALL2 | sal-like 2 (Drosophila) | 0.011 | ||
| DDX60 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 | 0.011 | ||
| LY6E | lymphocyte antigen 6 complex, locus E | 0.011 | ||
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.011 | ||
| AMOTL1 | angiomotin like 1 | 0.011 | ||
| IDE | insulin-degrading enzyme | 0.011 | ||
| PPIB | peptidylprolyl isomerase B (cyclophilin B) | 0.011 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.011 | ||
| SOX7 | SRY (sex determining region Y)-box 7 | 0.011 | Human | |
| PPRC1 | peroxisome proliferator-activated receptor gamma, coactivator-related 1 | 0.011 | ||
| PPP2R5C | protein phosphatase 2, regulatory subunit B', gamma | 0.011 | ||
| IFIT3 | interferon-induced protein with tetratricopeptide repeats 3 | 0.011 | ||
| ACTR2 | ARP2 actin-related protein 2 homolog (yeast) | 0.011 | ||
| STIP1 | stress-induced-phosphoprotein 1 | 0.011 | ||
| HIC1 | hypermethylated in cancer 1 | 0.011 | ||
| HERC5 | hect domain and RLD 5 | 0.011 | ||
| SCNN1A | sodium channel, nonvoltage-gated 1 alpha | 0.011 | ||
| CDC73 | cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) | 0.011 | ||
| MYD88 | myeloid differentiation primary response gene (88) | 0.011 | ||
| PTEN | phosphatase and tensin homolog | 0.011 | ||
| HPRT1 | hypoxanthine phosphoribosyltransferase 1 | 0.010 | ||
| RAD23B | RAD23 homolog B (S. cerevisiae) | 0.010 | ||
| TDRD7 | tudor domain containing 7 | 0.010 | ||
| TP73 | tumor protein p73 | 0.010 | ||
| RANBP2 | RAN binding protein 2 | 0.010 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.010 | ||
| PTK7 | PTK7 protein tyrosine kinase 7 | 0.010 | ||
| UBA2 | ubiquitin-like modifier activating enzyme 2 | 0.010 | ||
| SAE1 | SUMO1 activating enzyme subunit 1 | 0.010 | ||
| ALAS1 | aminolevulinate, delta-, synthase 1 | 0.010 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.010 |